Growth Metrics

Forte Biosciences (FBRX) Change in Account Payables (2016 - 2020)

Historic Change in Account Payables for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to $25000.0.

  • Forte Biosciences' Change in Account Payables fell 9663.98% to $25000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$369000.0, marking a year-over-year decrease of 13780.74%. This contributed to the annual value of $3.0 million for FY2024, which is 101476.01% up from last year.
  • As of Q4 2020, Forte Biosciences' Change in Account Payables stood at $25000.0, which was down 9663.98% from -$1.4 million recorded in Q3 2020.
  • Forte Biosciences' Change in Account Payables' 5-year high stood at $3.1 million during Q3 2018, with a 5-year trough of -$1.4 million in Q3 2020.
  • In the last 5 years, Forte Biosciences' Change in Account Payables had a median value of $50500.0 in 2016 and averaged $137850.0.
  • Per our database at Business Quant, Forte Biosciences' Change in Account Payables soared by 887352.94% in 2018 and then tumbled by 135277.78% in 2020.
  • Forte Biosciences' Change in Account Payables (Quarter) stood at -$278000.0 in 2016, then soared by 389.21% to $804000.0 in 2017, then plummeted by 237.69% to -$1.1 million in 2018, then soared by 167.21% to $744000.0 in 2019, then crashed by 96.64% to $25000.0 in 2020.
  • Its Change in Account Payables was $25000.0 in Q4 2020, compared to -$1.4 million in Q3 2020 and $1.9 million in Q2 2020.